Clinical trials
Shock, Hemorrhagic trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 2 |
| 2007 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 2 |
| 2016 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 5 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Terminated | 9 |
| Unknown status | 5 |
| Recruiting | 4 |
| Withdrawn | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Jason Sperry | 4 |
| Dartmouth-Hitchcock Medical Center | 2 |
| Denver Health and Hospital Authority | 2 |
| Dr. Hasan Alam | 2 |
| The University of Texas Health Science Center, Houston | 2 |
| University of Alabama at Birmingham | 2 |
| University of California, San Francisco | 2 |
| University of Washington | 2 |
| Arsenal Medical, Inc. | 1 |
| Baylor College of Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shock, Hemorrhagic | 35 |
| Wounds and Injuries | 17 |
| Hemorrhage | 12 |
| Accidental Injuries | 4 |
| Brain Injuries, Traumatic | 4 |
| Hemostatic Disorders | 4 |
| Multiple Trauma | 3 |
| Shock | 3 |
| Shock, Traumatic | 3 |
| Wounds, Penetrating | 3 |
Trials
Showing 26 to 35 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.